北美细胞治疗市场预测至 2027 年 - 按治疗类型（同种异体和自体）、产品（消耗品、设备、系统和软件）、技术（病毒载体技术、基因组编辑技术、体细胞技术）进行的 COVID-19 影响和区域分析、细胞永生化技术、细胞可塑性技术和三维技术）、应用（肿瘤学、心血管、骨科、伤口管理和其他应用）和最终用户（研究机构、医院等）和国家/地区
No. of Pages: 158 | Report Code: TIPRE00018850 | Category: Life Sciences
No. of Pages: 158 | Report Code: TIPRE00018850 | Category: Life Sciences
细胞疗法是注射、植入活体和完整细胞的过程，或移植到患者体内。这项技术依赖于用健康的功能细胞替代功能失调的细胞。主要用于此类先进疗法的细胞是干细胞，因为它们能够分化成修复受损或有缺陷的组织或细胞所需的特定细胞。此外，细胞疗法在再生医学的开发中也有应用。
北美细胞治疗市场预计将从2019年的2.9139亿美元增至2027年的14.0647亿美元。预计2020年至2027年该市场将以7.4%的复合年增长率增长推动市场增长的因素包括促进细胞疗法的合作不断加强，以及针对 COVID-19 的细胞疗法的发展。然而，严格的监管可能会限制预测期内的市场增长。
从治疗类型来看，2019年有异体、自体。同种异体细分市场在 2019 年占据了最大的市场份额。由于越来越重视创新和制造，人们越来越关注再生疗法的开发，预计该细分市场的增长。此外，大量批准用于临床的产品的可用性可能会在预测期内继续该细分市场的增长。然而，预计自体移植市场在预测期内的复合年增长率最高。
世界卫生组织、美国食品和药物管理局以及美国基因与药物学会细胞治疗和干细胞网络是报告中包含的北美细胞治疗市场的一些主要主要和次要来源。
Strategic insights for North America Cell Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 291.39 Million |
| Market Size by 2027 | US$ 1,406.47 Million |
| Global CAGR (2020 - 2027) | 7.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 治疗类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Cell Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Cell Therapy Market is valued at US$ 291.39 Million in 2019, it is projected to reach US$ 1,406.47 Million by 2027.
As per our report North America Cell Therapy Market, the market size is valued at US$ 291.39 Million in 2019, projecting it to reach US$ 1,406.47 Million by 2027. This translates to a CAGR of approximately 7.4% during the forecast period.
The North America Cell Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cell Therapy Market report:
The North America Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cell Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Cell Therapy Market
